News|Articles|June 24, 2026

Roundtable: The State of Hub Services in 2026

Author(s)Aimee Bugosh , Josh Marsh, Kristine McGaughey

Four patient services veterans on what's driving hub transitions in 2026, the digital tools reshaping how support is delivered, and what manufacturers need to get right to keep patients on therapy.

Pharma's investment in hub and patient access support services has grown sharply alongside the specialty pipeline. The global market for these services, valued at approximately $3.55 billion in 2025, is projected to nearly triple to $10 billion by 2035 as stakeholders navigate an increasingly complex landscape of high-cost therapies, payer friction, and more.¹